Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Opis bibliograficzny
Główni autorzy:	Mavaddat, N, Roalfe, A, Fletcher, K, Lip, G, Hobbs, R, Fitzmaurice, D, Mant, J
Format:	Journal article
Język:	English
Wydane:	2014

Podobne zapisy

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
od: Mavaddat, N, i wsp.
Wydane: (2014)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
od: Mant, J, i wsp.
Wydane: (2007)

Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
od: Mavaddat, N, i wsp.
Wydane: (2013)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
od: Mant, J, i wsp.
Wydane: (2008)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
od: Jowett, S, i wsp.
Wydane: (2011)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
od: Mant, J, i wsp.
Wydane: (2003)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
od: Fletcher Kate, i wsp.
Wydane: (2003-08-01)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
od: Hobbs, F, i wsp.
Wydane: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
od: Hobbs, R, i wsp.
Wydane: (2011)

A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
od: Roalfe, A, i wsp.
Wydane: (2012)

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
od: Hurley, V, i wsp.
Wydane: (2007)

Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study.
od: Fletcher, K, i wsp.
Wydane: (2010)

Warfarin versus aspirin for stroke prevention (BAFTA) - Reply
od: Mant, J, i wsp.
Wydane: (2007)

Anticoagulant management in patients with atrial fibrillation.
od: Fitzmaurice, D, i wsp.
Wydane: (2009)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
od: Mant, J, i wsp.
Wydane: (2007)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
od: I. Yu. Koroleva, i wsp.
Wydane: (2016-11-01)

Research into practice: management of atrial fibrillation in general practice.
od: Fitzmaurice, D, i wsp.
Wydane: (2014)

Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
od: Chan-Hyuk Lee, i wsp.
Wydane: (2019-05-01)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
od: Line Melgaard, i wsp.
Wydane: (2021-12-01)

Alcohol and Atrial Fibrillation
od: Stanisław Surma, i wsp.
Wydane: (2023-03-01)

Should we screen for atrial fibrillation?
od: Lown, M, i wsp.
Wydane: (2017)

The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
od: Bungard, T, i wsp.
Wydane: (2003)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
od: A. B. Sumarokov
Wydane: (2013-08-01)

Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture)
od: Y. V. Shubik
Wydane: (2015-12-01)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
od: Carolina eMalta Hansen, i wsp.
Wydane: (2012-06-01)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
od: Sana Rashid, i wsp.
Wydane: (2021-12-01)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
od: Touchette DR,, i wsp.
Wydane: (2008-03-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
od: Jean Michell Correia Monteiro, i wsp.

Atrial Fibrillation-Related Outcomes [Letter]
od: Naser A
Wydane: (2024-10-01)

SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS
od: E. L. Artanova, i wsp.
Wydane: (2016-01-01)

Management of atrial fibrillation
od: Puneet Kakar, i wsp.
Wydane: (2007-03-01)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
od: Fitzmaurice, D, i wsp.
Wydane: (1994)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C2HEST Score: The West Birmingham Atrial Fibrillation Project
od: Yan‐Guang Li, i wsp.
Wydane: (2021-03-01)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
od: van Walraven, C, i wsp.
Wydane: (2009)

Prevalence of atrial fibrillation in the general population and in high-risk groups: The ECHOES study
od: Davis, R, i wsp.
Wydane: (2012)

Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.
od: Davis, R, i wsp.
Wydane: (2012)

Stroke prevention in atrial fibrillation
od: Hobbs, F
Wydane: (2003)

Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy
od: Wang N, i wsp.
Wydane: (2024-05-01)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
od: Inche Mat, Liyana Najwa, i wsp.
Wydane: (2020)

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
od: Bungard, T, i wsp.
Wydane: (2001)